Evangelos Bouros

1.5k total citations
39 papers, 967 citations indexed

About

Evangelos Bouros is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Evangelos Bouros has authored 39 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 6 papers in Epidemiology. Recurrent topics in Evangelos Bouros's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (35 papers), Sarcoidosis and Beryllium Toxicity Research (8 papers) and Occupational and environmental lung diseases (5 papers). Evangelos Bouros is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (35 papers), Sarcoidosis and Beryllium Toxicity Research (8 papers) and Occupational and environmental lung diseases (5 papers). Evangelos Bouros collaborates with scholars based in Greece, United States and France. Evangelos Bouros's co-authors include Demosthenes Bouros, Αrgyris Τzouvelekis, Vasilios Tzilas, Paschalis Ntolios, Μarios E. Froudarakis, George Kolios, Anastasia Oikonomou, Argyrios Tzouvelekis, Athanassios Zissimopoulos and George Koliakos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and CHEST Journal.

In The Last Decade

Evangelos Bouros

39 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evangelos Bouros Greece 16 724 231 177 154 142 39 967
Paschalis Ntolios Greece 14 571 0.8× 162 0.7× 196 1.1× 97 0.6× 159 1.1× 35 774
Roberto Cassandro Italy 19 669 0.9× 346 1.5× 43 0.2× 120 0.8× 103 0.7× 41 1.0k
Jun Kishi Japan 17 462 0.6× 79 0.3× 49 0.3× 164 1.1× 100 0.7× 28 920
Elisa Lappi‐Blanco Finland 19 546 0.8× 121 0.5× 22 0.1× 128 0.8× 116 0.8× 41 809
Łukasz Wujak Germany 14 315 0.4× 61 0.3× 67 0.4× 224 1.5× 53 0.4× 21 688
Louis J. Vuga United States 11 900 1.2× 226 1.0× 17 0.1× 277 1.8× 76 0.5× 14 1.2k
N Balsara Germany 3 661 0.9× 59 0.3× 39 0.2× 438 2.8× 144 1.0× 3 984
Anna-Luise A. Katzenstein United States 7 577 0.8× 207 0.9× 25 0.1× 93 0.6× 155 1.1× 7 782
Paul D. Bozyk United States 8 441 0.6× 74 0.3× 109 0.6× 110 0.7× 250 1.8× 16 663
Angelo De Lauretis Italy 13 589 0.8× 140 0.6× 17 0.1× 147 1.0× 149 1.0× 20 927

Countries citing papers authored by Evangelos Bouros

Since Specialization
Citations

This map shows the geographic impact of Evangelos Bouros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evangelos Bouros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evangelos Bouros more than expected).

Fields of papers citing papers by Evangelos Bouros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evangelos Bouros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evangelos Bouros. The network helps show where Evangelos Bouros may publish in the future.

Co-authorship network of co-authors of Evangelos Bouros

This figure shows the co-authorship network connecting the top 25 collaborators of Evangelos Bouros. A scholar is included among the top collaborators of Evangelos Bouros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evangelos Bouros. Evangelos Bouros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tzilas, Vasilios, Argyrios Tzouvelekis, Stylianos Panopoulos, et al.. (2024). Presenting clinical and imaging features of patients with clinically amyopathic interstitial lung disease associated with myositis-specific autoantibodies. Frontiers in Medicine. 11. 1392659–1392659. 2 indexed citations
2.
Karampitsakos, Τheodoros, Christina Kalogeropoulou, Vasilios Tzilas, et al.. (2021). Safety and Effectiveness of Mycophenolate Mofetil in Interstitial Lung Diseases: Insights from a Machine Learning Radiographic Model. Respiration. 101(3). 262–271. 9 indexed citations
3.
Τzouvelekis, Αrgyris, et al.. (2020). Impact of Depression on Patients With Idiopathic Pulmonary Fibrosis. Frontiers in Medicine. 7. 29–29. 29 indexed citations
4.
Ntolios, Paschalis, Paschalis Steiropoulos, Georgia Karpathiou, et al.. (2020). Cell Therapy for Idiopathic Pulmonary Fibrosis: Rationale and Progress to Date. BioDrugs. 34(5). 543–556. 7 indexed citations
5.
Tzilas, Vasilios, Αrgyris Τzouvelekis, Evangelos Bouros, et al.. (2020). Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study. ERJ Open Research. 6(4). 152–2020. 20 indexed citations
6.
Karampitsakos, Τheodoros, Evangelos Bouros, Nektarios Anagnostopoulos, et al.. (2020). Increased Red Cell Distribution Width and Absolute Number of Monocytes Represent Negative Prognostic Markers in Patients with Idiopathic Pulmonary Fibrosis. A3377–A3377. 1 indexed citations
7.
Kishore, Amit, et al.. (2020). Association of TGF-β3 and ANXA11 with pulmonary sarcoidosis in Greek population. Expert Review of Respiratory Medicine. 14(10). 1065–1069. 11 indexed citations
8.
Τzouvelekis, Αrgyris, Georgia Gomatou, Evangelos Bouros, et al.. (2019). Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer. CHEST Journal. 156(2). 383–391. 108 indexed citations
9.
Tzilas, Vasilios, Evangelos Bouros, Ioanna Ninou, et al.. (2019). Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis. Pulmonary Pharmacology & Therapeutics. 55. 17–24. 64 indexed citations
10.
Τzouvelekis, Αrgyris, Τheodoros Karampitsakos, Evangelos Bouros, et al.. (2019). Autoimmune Biomarkers, Antibodies, and Immunologic Evaluation of the Patient with Fibrotic Lung Disease. Clinics in Chest Medicine. 40(3). 679–691. 6 indexed citations
11.
Magkrioti, Christiana, Nikos Oikonomou, Eleanna Kaffe, et al.. (2018). The Autotaxin—Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis. Cancer Research. 78(13). 3634–3644. 48 indexed citations
12.
Ntolios, Paschalis, Αrgyris Τzouvelekis, Evangelos Bouros, et al.. (2018). Longitudinal outcomes of patients enrolled in a phase Ib clinical trial of the adipose‐derived stromal cells‐stromal vascular fraction in idiopathic pulmonary fibrosis. The Clinical Respiratory Journal. 12(6). 2084–2089. 47 indexed citations
13.
Bouros, Evangelos, et al.. (2018). Respiratory Function in Wind Instrument Players. Materia Socio Medica. 30(2). 204–204. 5 indexed citations
14.
Tzouvelekis, Argyrios, Paschalis Ntolios, Τheodoros Karampitsakos, et al.. (2017). Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study. Pulmonary Pharmacology & Therapeutics. 46. 48–53. 37 indexed citations
15.
Bouros, Evangelos, Eirini Filidou, Konstantinos Arvanitidis, et al.. (2017). Lung fibrosis-associated soluble mediators and bronchoalveolar lavage from idiopathic pulmonary fibrosis patients promote the expression of fibrogenic factors in subepithelial lung myofibroblasts. Pulmonary Pharmacology & Therapeutics. 46. 78–87. 18 indexed citations
16.
Tzouvelekis, Argyrios, Τheodoros Karampitsakos, Paschalis Ntolios, et al.. (2017). Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece. Frontiers in Medicine. 4. 213–213. 35 indexed citations
17.
Τzouvelekis, Αrgyris, Evangelos Bouros, George Kolios, et al.. (2012). Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis. Pulmonary Medicine. 2012. 1–7. 50 indexed citations
18.
Τzouvelekis, Αrgyris, Evangelos Bouros, Anastasia Oikonomou, et al.. (2011). Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis. Pulmonary Medicine. 2011. 1–7. 14 indexed citations
19.
Τzouvelekis, Αrgyris, George Koliakos, Paschalis Ntolios, et al.. (2011). Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal. Journal of Translational Medicine. 9(1). 182–182. 55 indexed citations
20.
Bouros, Demosthenes, Αrgyris Τzouvelekis, & Evangelos Bouros. (2010). The Immunology of pulmonary fibrosis: The role of Th1/Th2/Th17/Treg cells. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paschalis Ntolios Breakdown of academic impact, for papers by Roberto Cassandro Breakdown of academic impact, for papers by Jun Kishi Breakdown of academic impact, for papers by Elisa Lappi‐Blanco Breakdown of academic impact, for papers by Łukasz Wujak Breakdown of academic impact, for papers by Louis J. Vuga Breakdown of academic impact, for papers by N Balsara Breakdown of academic impact, for papers by Anna-Luise A. Katzenstein Breakdown of academic impact, for papers by Paul D. Bozyk Breakdown of academic impact, for papers by Angelo De Lauretis
Rankless by CCL
2026